Tradestie Institutional Equity Comparison Engine

NGNE vs NBP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NBP Overall Edge

NBP Captures Institutional Edge (2โ€“2 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NBP (NBP) driven by superior Valuation, Options & Structure while NGNE counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, NGNE trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NBP at 2.7x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NGNE sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against NBP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner NBP
NGNE N/M vs NBP 2.7x Fwd P/E
Growth & Margin Winner NGNE
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner NGNE
1Y -12.0% vs -81.0% ยท 52W Pos 27% vs 0%
Options & Structure Winner NBP
BREAKDOWN (9th %ile IV) vs UNCLASSIFIED (N/A IV)
NGNE NASDAQ
Neurogene, Inc. Common Stock
Pharmaceutical Preparations
$23.30
-2.63% 1D
Market Cap $494.8M
1M Return +0.22%
1Y Return -12.04%
Forward P/E N/M
Unified AI Score
38.8 / 100 SELL
Tech 20.0 Fund 44.0 Flow 68.0 Mom 50.0
NBP US Equity
NBP
Institutional Equity
$0.79
-6.87% 1D
Market Cap $96.3M
1M Return -37.18%
1Y Return -81.02%
Forward P/E 2.7x
Unified AI Score
51.9 / 100 HOLD
Tech 60.0 Fund 50.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NGNE -12.04% NBP -81.02% Spread: +68.98 pp (NGNE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NGNE TTM Op. Margin: 0.0% NBP TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NGNE vs NBP. Trailing 12-month operating profitability (NGNE 0.0% vs NBP 0.0%) and valuation multiples (NGNE N/M vs NBP 2.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NGNE (3) vs NBP (4)
Institutional Metric NGNE NBP Criterion Row Winner
Market Capitalization Scale $494.8M $96.3M Larger Scale NGNE
Trailing P/E Ratio Valuation N/M 2.7x Lower Multiple NBP
Forward P/E Ratio Valuation N/M 2.7x Lower Multiple NBP
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -38.4% -59.1% Higher ROE NGNE
52-Week Range Position Momentum 27% ($16โ€“$44) 0% ($1โ€“$5) Stronger Trend NGNE
Beta / 30D Volatility Risk Regime 1.54ฮฒ ยท 89% Vol 1.64ฮฒ ยท 80% Vol Lower Realized Risk NBP
Unified Institutional Score Composite Signal 38.8 / 100 (SELL) 51.9 / 100 (HOLD) Higher Composite NBP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NGNE vs NBP Buy Guide
NGNE BREAKDOWN
91d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live NGNE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NBP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NBP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NGNE nor NBP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.